Taf15 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
TAF15 (TATA-Binding Protein Associated Factor 15) is an RNA-binding protein and transcription factor involved in transcriptional regulation and RNA processing. It belongs to the FET (FUS, EWSR1, TAF15) family of proteins implicated in ALS and FTD. [@ratti2020]
Taf15 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
TAF15 (TATA-Binding Protein Associated Factor 15) is an RNA-binding protein and transcription factor involved in transcriptional regulation and RNA processing. It belongs to the FET (FUS, EWSR1, TAF15) family of proteins implicated in ALS and FTD. [@ratti2020]
Overview
Mermaid diagram (expand to render)
Function
TAF15 contains an N-terminal transcriptional activation domain and a C-terminal RNA recognition motif (RRM) domain, allowing it to function in both transcription and RNA processing.
Key Molecular Functions
Transcriptional Regulation: Activates transcription as part of the TFIID complex
RNA Splicing: Regulates alternative splicing of pre-mRNA
Stress Granule Formation: Localizes to stress granules under cellular stress
RNA Transport: Involved in neuronal RNA transport granules
Disease Associations
ALS (Amyotrophic Lateral Sclerosis)
TAF15 mutations are rare causes of familial ALS
Forms cytoplasmic inclusions in ALS motor [neurons](/entities/neurons)
Co-aggregates with FUS and [TDP-43](/proteins/tdp-43) in ALS pathology
RRM domain mutations affect RNA binding affinity
FTD (Frontotemporal Dementia)
TAF15 inclusions found in FTD subtypes
Genetic variants associated with FTD risk
Dysregulated expression in FTD brain tissue
Cancer
TAF15 was originally identified as an oncogene (NOCA1)
TAF15-NUTM fusion in sarcomas and carcinomas
Expression
TAF15 is expressed in most tissues with highest expression in:
In neurons, TAF15 localizes to both nucleus and cytoplasm.
Key Publications
Mutations in TAF15 in ALS - Nat Neurosci. 2014;17(5):664-666.
FET proteins in neurodegeneration - Nat Rev Neurol. 2019;15(10):615-629.
TAF15 stress granules in ALS - Acta Neuropathol. 2020;139(2):247-269.
FUS and TAF15 in RNA metabolism - J Mol Biol. 2018;430(18):3021-3044.
Clinical Significance
TAF15 mutations are associated with:
ALS: R526H and other missense mutations cause familial ALS
FTD: TAF15 inclusions found in some FTD cases
Sarcoma: TAF15 fusions in certain cancers
Neurodegeneration: RNA granule aggregation in disease
Therapeutic Approaches
Research focuses on:
Antisense oligonucleotide therapy
Small molecule aggregation inhibitors
RNA granule modulators
Gene therapy for loss-of-function mutations
Background
The study of Taf15 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Clinical Significance
TAF15 mutations are associated with:
ALS: R526H and other missense mutations cause familial ALS
FTD: TAF15 inclusions found in some FTD cases
Sarcoma: TAF15 fusions in certain cancers
Neurodegeneration: RNA granule aggregation in disease